If you want to save for the college education of your child, you may want to look into a 529 college savings plan. This is an investment vehicle designed to fund higher education for a beneficiary,...
The United States is one of the largest arms manufacturers in the world, especially when it comes to small arms. Despite the robust portfolio of guns that the U.S. produces annually, the U.S....
Shares of General Motors are indicated down over 2% ahead of the open today at $30.40 on a negative research note out of Goldman Sachs.  Goldman trimmed GM’s estimates and the target on...
Of the top 25 price gainers today, 15 are gold or silver miners, most are the juniors, and all are up about 9%-12%. Recent weak US employment news and a pricey dollar-euro exchange is sending...
Chewing gum was a childhood rite for most Americans. Back in elementary school, gum was tantamount to currency. A few pieces of gum could immediately turn you into one of the most powerful and...
Goldman Sachs Group Inc. (NYSE: GS) stunk this week when it reported one of its few operating losses ever.  What is interesting is that shares have risen with the banking sector.  The loss may have...
The U.S. military embodies the military doctrine of constantly advancing and improving its technology to better equip its soldiers. This principle holds especially true with the small arms that are...
A great deal has been made about the Nasdaq going from being down 25% for the year to being up for 2009. The furious rally might continue, but it probably won’t. That is not because the economy is...
There were two ghastly research calls this week from separate firms on separate companies.  While one is more severe than the other, these two analyst downgrades are essentially a tie for the...
These are the top ten analyst calls for research upgrades, downgrades, and initiations which we have seen from Wall Street early this Monday morning: Airgas (ARG) Started as Buy at Piper Jaffray....
From Ticker Sense In this month’s ISM commodities survey, respondents said they saw price increases in five commodities and price decreases in six, for a net of minus one.  Below we have updated...
GlaxoSmithKline (GSK) wants everyone, including the FDA, to know that its diabetes drug Avadia is "safe and effective when used appropriately." Almost everyone else thinks that the drug...
The U.S. Centers for Medicare & Medicaid Services issued its final ruling governing use of a class of anemia drugs including Amgen’s (AMGN) Aranesp .The CMOS guided doctors to restrict the...
This is getting completely swept under the table because of the stock market flush-out.  But we have been awaiting the announcement confirming last week’s reports of a venture between Intel...
After bad-mouthing research attacking its diabetes drug Avandia, word now comes from The New York Times that GlaxoSmithKline (GSK) attempted to intimidate a well-known diabetes researcher, Dr. John...